Outpatient Treatment for Intestinal Amoebiasis
For intestinal amoebiasis, treat with metronidazole 500 mg three times daily for 7-10 days (or tinidazole 2g daily for 3 days as an alternative with less nausea), followed by a luminal amoebicide such as paromomycin 30 mg/kg/day in 3 divided doses for 10 days or diloxanide furoate 500 mg three times daily for 10 days. 1
Treatment Algorithm
Step 1: Tissue-Active Agent (Kills Invasive Trophozoites)
Primary option:
- Metronidazole 500 mg orally three times daily for 7-10 days
- Achieves >90% cure rate 1
Alternative option:
- Tinidazole 2g orally once daily for 3 days
- Results in significantly less nausea than metronidazole 1
- Higher cure rates (96.5% vs 55.5%) and better tolerated than metronidazole in comparative studies 2
Step 2: Luminal Amoebicide (Essential - Prevents Relapse)
This second phase is mandatory for all patients, even those with negative stool microscopy, as it reduces relapse risk by eliminating intestinal colonization 1
Choose one:
- Paromomycin 30 mg/kg/day orally in 3 divided doses for 10 days 1
- Diloxanide furoate 500 mg orally three times daily for 10 days 1
Key Clinical Points
Diagnosis considerations:
- Stool microscopy for Entamoeba histolytica trophozoites or cysts
- Stool antigen detection tests (preferred over microscopy alone) 3, 4
- Serology has >90% sensitivity for invasive disease but less useful for uncomplicated intestinal infection 1
Common pitfall: The most critical error is failing to administer the luminal amoebicide after completing metronidazole/tinidazole. Metronidazole alone does not adequately clear intestinal colonization, leading to relapse rates of approximately 40-45% without luminal therapy 5. The two-phase treatment is not optional—it is essential for cure.
When to consider hospitalization:
- Evidence of systemic inflammatory response syndrome
- Suspected hepatic abscess (right upper quadrant pain, fever, hepatomegaly)
- Severe colitis with bloody diarrhea and systemic toxicity
- Inability to tolerate oral medications
Alternative emerging therapy: Nitazoxanide 500 mg twice daily for 3 days showed 94% cure rates in intestinal amoebiasis and may eliminate the need for two-phase therapy, though this requires further validation 6. Currently, the metronidazole/tinidazole plus luminal amoebicide regimen remains standard of care.
Drug tolerance: Tinidazole causes less nausea and gastrointestinal side effects than metronidazole while achieving superior cure rates, making it the preferred tissue-active agent when available 2. However, metronidazole remains widely used due to cost and availability.